Pharmacomicrobiomics in precision cancer therapy: bench to bedside.

Khanh Le Ngoc; Tran Thu Ha Pham; Tiep Khac Nguyen; Phung Thanh Huong

The burgeoning field of pharmacomicrobiomics offers promising insights into the intricate interplay between the microbiome and cancer, shaping responses to diverse treatment modalities. This review aims to analyze the molecular mechanisms underlying interactions between distinct microbiota types and cancer, as well as their influence on treatment outcomes. We explore how the microbiome impacts antitumor immunity, and response to chemotherapy, immunotherapy, and radiation therapy, unveiling its multifaceted roles in cancer progression and therapy resistance. Moreover, we discuss the challenges hindering the development of microbiome-based interventions in cancer therapy, including standardization, validation, and clinical translation. By synthesizing clinical evidence, we underscore the transformative potential of harnessing pharmacomicrobiomics in guiding cancer treatment decisions, paving the way for improved patient outcomes in clinical practice.

CANCER treatment; RADIOTHERAPY; TREATMENT effectiveness; CANCER invasiveness; INDIVIDUALIZED medicine

Frontiers in Immunology, 2024, p1

1664-3224

Academic Journal

10.3389/fimmu.2024.1428420